This invention relates to new monophosphonate compounds of formula X-C6H4-(O)m-(CH2)n-R where R is -P03Me2, -P03Et2, -P03H2 or -PO3Na2, X is a halogen, preferably chlorine, in position o, m or p, preferably in position p; m is 0 or 1; and n is 0, 1, 2, 3, 4, 5 or 6, which possess remarkable activity as hypoglycemic and/ or antiatherogenic agents, and are usable in pharmaceutical compositions to alter lipoprotein profiles in favour of high density lipoproteins and to clear cholesterol from various tissues.
本发明涉及式 X-
C6H4-(O)m-(
CH2)n-R的新单
膦酸盐化合物,其中 R 是-P03Me2、-P03Et2、-P03H2 或-PO3Na2,X 是卤素,最好是
氯,位于 o、m 或 p 位,最好位于 p 位;m 是 0 或 1;这些化合物作为降血糖剂和/或抗动脉粥样硬化剂具有显著的活性,可用于药物组合物中,以改变脂蛋白谱,使其有利于高密度脂蛋白,并清除各种组织中的
胆固醇。